51 天前 - … is an emerging field of research owing to its pathophysiological relevance to a
wide range of neurological disorders, including Alzheimer's and Parkinson's diseases and …

51 天前 - … being realized for neurodegenerative diseases in advanced … immunotherapies in
Parkinson’s and Alzheimer’s diseases. … in clinical trials for Parkinson disease (not all trials of a …

52 天前 - … Parkinson's disease (PD) is a progressive neurodegenerative disease, and it is
caused by the loss of dopaminergic neurons in the basal ganglia (BG). Currently, there is no …

55 天前 - … array of topics that emerged from the rich texture of … diseases, notably Parkinson’s
disease (PD), where a repurposing strategy involving Type 2 Diabetes Mellitus (T2DM) drugs …

59 天前 - … course of the disease. The emerging healthcare paradigm of precision medicine
aims to address these challenges by bringing the right drug to the right patient at the right time. …

60 天前 - … Motor complications were more common among those with higher drug doses,
younger … ), with associations emerging 2–4 years post‐diagnosis. Higher Parkinson's GRS was …

66 天前 - … Fragment-based drug discovery (FBDD) has emerged as a powerful strategy to
confront the challenges faced by conventional drug development approaches, particularly in the …

68 天前 - Background: Pharmacogenomics is now recognized as a valuable tool for guiding
personalized and precise treatments, minimizing adverse events, and enhancing drug …

74 天前 - … Understanding spatial lipid biology in nervous tissue is therefore a key and emerging
… MPTP-lesioned macaque brain tissue, a Parkinson's disease animal model. The lateral …

74 天前 - … form the cornerstone of Parkinson’s disease (PD) treatment. … Motor deficits gradually
emerged over four re-exposure … for individuals with Parkinson disease may unlock benefits…